B Rockhill1, P G Moorman, B Newman. 1. Channing Laboratory and Harvard School of Public Health, Boston 02115, MA, USA.
Abstract
OBJECTIVES: Later menarche, and a longer time until onset of regular cycling, are considered markers of lower lifetime exposure to circulating ovarian hormones. While later age at menarche is associated with reduced breast cancer risk, evidence for the relationship between time until onset of regular cycles and breast cancer is inconsistent. We evaluated both associations with breast cancer risk. METHODS: We used data from the Carolina Breast Cancer Study, a population-based case-control study of breast cancer among White and Black women aged 20 to 74 years, residing in central and eastern North Carolina (United States). Cases were diagnosed between May 1993 and June 1996. Unconditional logistic regression models were limited to women with complete data for the risk factors considered (n = 830 cases, 758 controls). RESULTS: We observed an inverse relationship between age at menarche and breast cancer risk, but found little support for the hypothesis that a longer time until onset of regular menstrual cycling was associated with reduced risk of breast cancer (odds ratios = 1.0 [95 percent confidence interval (CI) = 0.7-1.5], and 1.2 [CI = 0.8-1.6], respectively, for 1-4 years and < 1 year until onset of regular cycling, relative to 5+ years). There was little relationship between age at menarche and time until regular cycling. We found strong evidence that delays in onset of regular cycling were associated with increased frequency of irregular cycles throughout young adulthood. CONCLUSIONS: Given the inconsistent findings regarding the links between menstrual cycle characteristics and breast cancer, and recent recommendations to delay menarche and alter the patterns of cycles of young women in order to reduce breast cancer risk, this topic calls for further, innovative study.
OBJECTIVES: Later menarche, and a longer time until onset of regular cycling, are considered markers of lower lifetime exposure to circulating ovarian hormones. While later age at menarche is associated with reduced breast cancer risk, evidence for the relationship between time until onset of regular cycles and breast cancer is inconsistent. We evaluated both associations with breast cancer risk. METHODS: We used data from the Carolina Breast Cancer Study, a population-based case-control study of breast cancer among White and Black women aged 20 to 74 years, residing in central and eastern North Carolina (United States). Cases were diagnosed between May 1993 and June 1996. Unconditional logistic regression models were limited to women with complete data for the risk factors considered (n = 830 cases, 758 controls). RESULTS: We observed an inverse relationship between age at menarche and breast cancer risk, but found little support for the hypothesis that a longer time until onset of regular menstrual cycling was associated with reduced risk of breast cancer (odds ratios = 1.0 [95 percent confidence interval (CI) = 0.7-1.5], and 1.2 [CI = 0.8-1.6], respectively, for 1-4 years and < 1 year until onset of regular cycling, relative to 5+ years). There was little relationship between age at menarche and time until regular cycling. We found strong evidence that delays in onset of regular cycling were associated with increased frequency of irregular cycles throughout young adulthood. CONCLUSIONS: Given the inconsistent findings regarding the links between menstrual cycle characteristics and breast cancer, and recent recommendations to delay menarche and alter the patterns of cycles of young women in order to reduce breast cancer risk, this topic calls for further, innovative study.
Authors: Jessica S B Beiler; Kangmin Zhu; Sandra Hunter; Kathleen Payne-Wilks; Chanel L Roland; Vernon M Chinchilli Journal: J Natl Med Assoc Date: 2003-10 Impact factor: 1.798
Authors: Leslie V Farland; Fan Mu; A Heather Eliassen; Susan E Hankinson; Shelley S Tworoger; Robert L Barbieri; Mitch Dowsett; Michael N Pollak; Stacey A Missmer Journal: Cancer Causes Control Date: 2017-10-31 Impact factor: 2.506
Authors: Mary Beth Terry; Mandy Goldberg; Sarah Schechter; Lauren C Houghton; Melissa L White; Karen O'Toole; Wendy K Chung; Mary B Daly; Theresa H M Keegan; Irene L Andrulis; Angela R Bradbury; Lisa Schwartz; Julia A Knight; Esther M John; Saundra S Buys Journal: Pediatrics Date: 2016-06-08 Impact factor: 7.124
Authors: Ellen W Demerath; Ching-Ti Liu; Nora Franceschini; Gary Chen; Julie R Palmer; Erin N Smith; Christina T L Chen; Christine B Ambrosone; Alice M Arnold; Elisa V Bandera; Gerald S Berenson; Leslie Bernstein; Angela Britton; Anne R Cappola; Christopher S Carlson; Stephen J Chanock; Wei Chen; Zhao Chen; Sandra L Deming; Cathy E Elks; Michelle K Evans; Zofia Gajdos; Brian E Henderson; Jennifer J Hu; Sue Ingles; Esther M John; Kathleen F Kerr; Laurence N Kolonel; Loic Le Marchand; Xiaoning Lu; Robert C Millikan; Solomon K Musani; Nora L Nock; Kari North; Sarah Nyante; Michael F Press; Jorge L Rodriquez-Gil; Edward A Ruiz-Narvaez; Nicholas J Schork; Sathanur R Srinivasan; Nancy F Woods; Wei Zheng; Regina G Ziegler; Alan Zonderman; Gerardo Heiss; B Gwen Windham; Melissa Wellons; Sarah S Murray; Michael Nalls; Tomi Pastinen; Aleksandar Rajkovic; Joel Hirschhorn; L Adrienne Cupples; Charles Kooperberg; Joanne M Murabito; Christopher A Haiman Journal: Hum Mol Genet Date: 2013-04-17 Impact factor: 6.150